Advertisement

Prognosis of Endometrial Carcinoma

Chapter
  • 44 Downloads

Abstract

In the FIGO Annual Report (1985), 5-year survival was 67.7% in 13 581 cases of endo-metrial carcinoma (Table 5.1). The reported figures of survival have been consistent, ranging from 66% to 77% (Frick et al. 1973; Morrow et al. 1973; Berman et al. 1980; Connelly et al. 1982; Kauppila et al. 1982). Li (1988), reviewing 418 cases of endometrial carcinoma, found 5-year survival to be 77.6% for stage I, 59.6% for stage II, and 61.9% for stages I–IV respectively. The low mortality is probably related to the fact that over 80% of the cases were confined to the uterus (FIGO stages I, II) at initial diagnosis and approximately 75% of cases could be treated by surgery and/or radiotherapy.

Keywords

Endometrial Cancer Obstet Gynecol Endometrial Carcinoma Myometrial Invasion Adenosquamous Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aalders JG, Abeier V, Kolstad P et al. (1980) Post-operative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56:419–427PubMedGoogle Scholar
  2. Aalders JG, Abeler V, Kolstad P (1984a) Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol Oncol 17:85–103PubMedCrossRefGoogle Scholar
  3. Aalders JG, Abeler V, Kolstad P (1984b) Stage IV endometrial carcinoma: a clinical and histopathological study of 83 patients. Gynecol Oncol 17:75–84PubMedCrossRefGoogle Scholar
  4. Alberhasky RC, Connelly PJ, Christopherson WM (1982) Carcinoma of the endometrium. IV. Mixed adenosquamous carcinoma. Am J Clin Pathol 77:655–664PubMedGoogle Scholar
  5. Austin JH, MacMahon B (1969) Indicators of prognosis in carcinoma of the corpus uteri. Surg Gynecol Obstet 128:1247–1252PubMedGoogle Scholar
  6. Baram A, Figer A, Inbar M et al. (1985) Endometrial carcinoma stage I - comparison of two different treatment regimes — evaluation of risk factors and its influence on prognosis; suggested step by step treatment protocol. Gynecol Oncol 22:294–301PubMedCrossRefGoogle Scholar
  7. Berman ML, Barlow SC, Lagasse LD et al. (1980) Prognosis and treatment of endometrial cancer. Am J Obstet Gynecol 136:679–688PubMedGoogle Scholar
  8. Boronow RC (1977) Endometrial cancer: staging, pre-treatment evaluation and factors in outcome. In: Gray LA Sr (ed) Endometrial carcinoma and its treatment: the role of irradiation, extent of surgery, and approach to chemotherapy, vol III. Thomas, Springfield, p 38–57Google Scholar
  9. Boronow RC, Morrow CP, Creasman WT et al. (1984) Surgical staging of endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 63:825–838PubMedGoogle Scholar
  10. Boutselis JG (1978) Endometrial carcinoma: prognostic factors and treatment. Surg Clin North Am 58:109–119PubMedGoogle Scholar
  11. Bruckman JE, Goodman RL, Murthy A, Marck A (1978) Combined irradiation and surgery in the treatment of stage II carcinoma of the endometrium. Cancer 42:1146–1151PubMedCrossRefGoogle Scholar
  12. Chen SS (1985) Extrauterine spread in endometrial carcinoma clinically confined to the uterus. Gynecol Oncol 21:23–31PubMedCrossRefGoogle Scholar
  13. Cheon H (1969) Prognosis of endometrial carcinoma. Obstet Gynecol 34:680–684PubMedGoogle Scholar
  14. Climie ARW, Rachmaninoff N (1965) A ten year experience with endometrial carcinoma. Surg Gynecol Obstet 120:73–78PubMedGoogle Scholar
  15. Connelly PJ, Alberhasky RC, Christopherson WM (1982) Carcinoma of the endometrium III. Analysis of 865 cases of adenocarcinoma and adeno-canthoma. Obstet Gynecol 59:569PubMedGoogle Scholar
  16. Corscaden JA, Tovell HMM (1954) The management of carcinoma of the corpus. Am J Obstet Gynecol 68:737–760PubMedGoogle Scholar
  17. Creasman WT, Rutledge FN (1971) The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol 110:773–781PubMedGoogle Scholar
  18. Creasman WT, Borrow RC, Morrow CP et al. (1976) Adenocarcinoma of the endometrium: its metastatic lymph node potential. A preliminary report. Gynecol Oncol 4:239–243PubMedCrossRefGoogle Scholar
  19. Creasman WT, McCarty KS, Sr, Barton TK et al. (1980) Clinical correlates of estrogen and progesterone-binding proteins in human endometrial adenocarcinoma. Obstet Gynecol 55:363–370PubMedGoogle Scholar
  20. Creasman WT, DiSaia PJ, Blessing J et al. (1981) Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol 141:921–929PubMedGoogle Scholar
  21. DeMuelenaere GF (1975) Prognostic factors in endometrial carcinoma. S Afr Med J 49:1695–1698Google Scholar
  22. DiSaia PJ, Creasman WT (1981) Adenocarcinoma of the uterus. In: DiSaia PJ, Creasman WT (eds) Clinical gynecologic oncology. Mosby, St Louis, p 128–151Google Scholar
  23. DeSombre ER, Greene GL, King WT, Jensen EV (1984) Estrogen receptors, antibodies and hormone dependent cancer. In: Gurpide E, Calandra, Levy C, Soto RJ (eds) Hormones and Cancer. Liss, New York, Vol 142 1–21Google Scholar
  24. Ehrlich CE, Young PCM, Cleary RE (1981) Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications. Am J Obstet Gynecol 141:539–546PubMedGoogle Scholar
  25. Emge LA (1962) The elusive adenomyosis of the uterus. Am J Obstet Gynecol 83:1541–1563PubMedGoogle Scholar
  26. FIGO (1985) Annual report 19:126Google Scholar
  27. Friberg LG, Kullander S, Persijn JP, Korsten CB (1978) On receptors for estrogen (E2) and androgens (DHT) in human endometrial carcinoma and ovarian tumours. Acat Obstet Gynecol Scand 57:265–271CrossRefGoogle Scholar
  28. Frick HC, Munnell EW, Richart RM et al. (1973) Carcinoma of endometrium. Am J Obstet Gynecol 115:663–676PubMedGoogle Scholar
  29. Gagnon JD, Moss WT, Gabourel LS, Stevens KR (1979) External irradiation in the management of stage II endometrial carcinoma. Cancer 44:1247–1251PubMedCrossRefGoogle Scholar
  30. Giammalvo JT, Kaplan K (1958) The incidence of endometriosis interna in 120 cases of carcinoma of the endometrium. Am J Obstet Gynecol 75:161–166PubMedGoogle Scholar
  31. Greenwood SM (1976) The relation of adenomyosis uteri to coexistent endometrial carcinoma and endometrial hyperplasia. Obstet Gynecol 48:68–72PubMedGoogle Scholar
  32. Grilli S, Ferrari AM, Gola G et al. (1977) Cytoplasmic receptors for 17β-estradiol, 5α-dihydrotestosterone and progesterone in normal and abnormal human uterine tissue. Cancer Lett 2:247–258PubMedCrossRefGoogle Scholar
  33. Gusberg SB, Yannopoulos D (1964) Therapeutic decision in corpus cancer. Am J Obstet Gynecol 88:157–162PubMedGoogle Scholar
  34. Gusberg SB (1978) Cancer of the endometrium: diagnosis and histogenesis. Corscaden’s gynecologic cancer, 5th edn. Williams and Wilkins, Baltimore, p 265–300Google Scholar
  35. Hall JB, Young RH, Nelson JH (1984) The prognostic significance of adenomyosis in endometrial carcinoma. Gynecol Oncol 17:32–40PubMedCrossRefGoogle Scholar
  36. Hawksworth W (1964) The treatment of carcinoma of the body of the uterus. Proc R Soc Med 57:467–478Google Scholar
  37. Healy WR, Brown RL (1939) Experience with surgical and radiation therapy in carcinoma of the corpus uteri. Am J. Obstet Gynecol 38:1Google Scholar
  38. Hernandez E, Woodruff JD (1980) Endometrial adenocarcinoma arising in adenomyosis. Am J Obstet Gynecol 138:827–832PubMedGoogle Scholar
  39. Homesley HD, Boronow RC, Lewis JL (1976) Treatment of adenocarcinoma of the endometrium at Memorial-James Ewing Hospital 1949–1965. Obstet Gynecol 47:100–105PubMedGoogle Scholar
  40. Homesley HD, Boronow RC, Lewis JL Jr. (1977) Stage II endometrial adenocarcinoma: Memorial Hospital for cancer, 1949–1965. Obstet Gynecol 49:604–608PubMedGoogle Scholar
  41. Hunter RE, Longcope C, Jordon VC (1980) Steroid hormone receptors in adenocarcinoma of the endometrium. Gynecol Oncol 10:152–161PubMedCrossRefGoogle Scholar
  42. Joelsson I, Levine RV, Moberger G (1971) Hysteroscopy as an adjunct in determining the extent of carcinoma of the endometrium. Am J Obstet Gynecol 111:696–702PubMedGoogle Scholar
  43. Johnsson JE (1979) Recurrences and metastasis in carcinoma of the uterine body correlated to the size and localization of the primary tumor. Acta Obstet Gynecol Scand 58:405–408PubMedCrossRefGoogle Scholar
  44. Jones HW (1975) Treatment of adenocarcinoma of the endometrium. Obstet Gynecol Surv 30:147–169PubMedCrossRefGoogle Scholar
  45. Kauppila A, Grönroos M, Niemineu U (1982) Clinical outcome of endometrial cancer. Obstet Gynecol 60:473–480PubMedGoogle Scholar
  46. Keller D, Kempson RL, Levine G, McLennan C (1974) Management of the patient with early endometrial carcinoma. Cancer 33:1108–1116PubMedCrossRefGoogle Scholar
  47. Lewis BV, Stallworthy JA, Cowdell R (1970) Adenocarcinoma of the body of the uterus. J Obstet Gynecol Br Commonw 77:343–348CrossRefGoogle Scholar
  48. Li SY (1988) Prognosis of endometrial carcinoma. In: Li SY (ed) Endometrial carcinoma. People’s Medical Publishing House, Beijing, p 169–198Google Scholar
  49. Li SY, Liu ZM (1984) Estrogen and progesterone receptor in endometrial carcinoma and treatment with 17a-hydroxyprogesterone caproate. J Chin Oncol 6:429–431Google Scholar
  50. Li SY, Wang EY, Li JX et al. (1988) Estrogen receptor and progesterone receptor assay as an index of response to hormone therapy in endometrial cancer. J Practical Oncol 2(4):28–32Google Scholar
  51. Lutz MH, Underwood PB Jr, Kreutner A Jr, Miller MC (1978) Endometrial carcinoma: a new method of classification of therapeutic and prognostic significance. Gynecol Oncol 6:83–94PubMedCrossRefGoogle Scholar
  52. MacLaughlin DT, Richardson GS (1976) Progesterone binding by normal and abnormal human endometrium. J Clin Endocrinol Metab 42:667–678PubMedCrossRefGoogle Scholar
  53. Malkasian GD, Annegers JF, Fountain KS (1980) Carcinoma of the endometrium: stage I. Am J Obstet Gynecol 136:872–888PubMedGoogle Scholar
  54. Manetta A, Delgado G, Petrilli E et al. (1986) The significance of paraaortic node status in carcinoma of the cervix and endometrium. Gynecol Oncol 23:284–290PubMedCrossRefGoogle Scholar
  55. Marcus CC (1962) Relationship of adenomyosis uteri to endometrial hyperplasia and endometrial carcinoma. Am J Obstet Gynecol 82:408–416Google Scholar
  56. Martin PM, Rolland PH, Gammerre M et al. (1979) Estradiol and progesterone receptors, histopathological examinations and clinical responses under progestin therapy. Int J Cancer 23:321–329PubMedCrossRefGoogle Scholar
  57. Mattingly RF (1977) Malignant tumors of the uterus. Mattingly RF, Thompson JD (eds) In: Telinde’s Operative Gynecology, 5th edn. Lippincott, Philadelphia, p 845–876Google Scholar
  58. McCarty KS Jr, Barton TK, Fetter BF et al. (1979) Correlation of estrogen and progesterone receptors with histological differentiation in endometrial adenocarcinoma. Am J pathol 96:171–182PubMedGoogle Scholar
  59. Milton PJD, Metters JS (1972) Endometrial carcinoma — an analysis of 355 patients treated at St Thomas Hospital, 1945–1969. J Obstet Gynecol Br Commonw 79:455CrossRefGoogle Scholar
  60. Molitor JJ (1971) Adenomyosis: a clinical and pathological appraisal. Am J Obstet Gynecol 110:275–282PubMedGoogle Scholar
  61. Mori T, Silverberg SG (1984) Endometrial carcinoma: nontumor factors in prognosis. Gynecol Oncol 17:259CrossRefGoogle Scholar
  62. Morrow CP, DiSaia PJ, Townsend DE (1973) Current management of endometrial carcinoma. Obstet Gynecol 42:399–408PubMedGoogle Scholar
  63. Morrow CP, Creasman WT, Homesley H et al. (1986) Recurrence in endometrial carcinoma as a function of extended surgical staging data. In: Morrow CP, Smart GE (eds) Gynecological oncology. Springer, Berlin Heidelberg New York, p 147–153CrossRefGoogle Scholar
  64. Nahhas WA, Lund CJ, Rudolph JH (1971) Carcinoma of the corpus uterine: a 10-year review of 225 patients. Obstet Gynecol 38:564–570PubMedCrossRefGoogle Scholar
  65. Ng ABP, Reagan JW (1970) Incidence and prognosis of endometrial carcinoma by histologic grade and extent. Obstet Gynecol 35:437–443PubMedGoogle Scholar
  66. Nilson PA, Koller O (1969) Carcinoma of the endometrium in Norway, 1957–1960, with special reference to treatment results. Am J Obstet Gynecol 105:1099–1109Google Scholar
  67. Nolan JF, Huen A (1976) Prognosis in endometrial cancer. Gynecol Oncol 4:384–390PubMedCrossRefGoogle Scholar
  68. Ostor AG, Adam R, Gutteridge BH et al. (1982) Endometrial carcinoma in young women. Aust NZ J Obstet Gynecol 22:38–42CrossRefGoogle Scholar
  69. Owelabi TO, Stickler RC (1977) Adenomyosis - a neglected diagnosis. Obstet Gynecol 50:424–427Google Scholar
  70. Piver MS, Lele SB, Barlow JJ et al. (1982) Paraaortic lymph node evaluation in stage I endometrial carcinoma. Obstet Gynecol 59:97–100PubMedGoogle Scholar
  71. Plentl AA, Friedman AE (1971) Lymphatic system of the female genitalia. Saunders, Philadelphia, p 135Google Scholar
  72. Prem KA, Adcock LL, Okagaki T, Jones TK (1979) The evolution of a treatment program for adenocarcinoma of the endometrium. Am J Obstet Gynecol 133:803PubMedGoogle Scholar
  73. Prodi G, DeGiovanni C, Galli MC et al. (1979) 17β-Estradiol, 5α-dihydrotestosterone, progesterone and cortisol receptors in normal and neoplastic human endometrium. Tumori 65:241–253PubMedGoogle Scholar
  74. Reagan JW, Fu YS (1981) Pathology of endometrial carcinoma. In: Coppleson M (ed) Gynecologic oncology. Churchill Livingstone, Edinburgh, p. 546–570Google Scholar
  75. Rutledge FN (1974) The role of radical hysterectomy in adenocarcinoma of the endometrium. Gynecol Oncol. 2:331–347PubMedCrossRefGoogle Scholar
  76. Sall S, Sonnenblick B, Stone ML (1970) Factors affecting survival of patients with endometrial adenocarcinoma. Am J Obstet Gynecol 107:116–123PubMedGoogle Scholar
  77. Silverberg SG, Bolin MG, DeGiorgi LS (1972) Adenoacanthoma and mixed adenosquamous carcinoma of the endometrium: a clinico-pathological study. Cancer 30:1307–1314PubMedCrossRefGoogle Scholar
  78. Silverberg SG, Makowski EL (1975) Endometrial carcinoma in young women taking oral contraceptive agents. Obstet Gynecol 46:503–506PubMedGoogle Scholar
  79. Sommers SC (1973) Carcinoma of endometrium. In: Norris JH, Hertig AT, Abell MR (eds) The uterus. Williams and Wilkins, Baltimore, p 276–298Google Scholar
  80. Soutter WP, Hamilton K, Leake RE (1979) High affinity binding of estradiol-17β in the nuclei of human endometrial cells. J Steroid Biochem 10:529–534PubMedCrossRefGoogle Scholar
  81. Spona J, Ulm R, Bieglmayer C, Husslein P (1979) Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma. Gynecol Obstet Invest 10:71–80PubMedCrossRefGoogle Scholar
  82. Surwit EA, Fowler WC Jr, Rogoff EE (1978) Stage II carcinoma of the endometrium: an analysis of treatment. Obstet Gynecol 52:97–99PubMedGoogle Scholar
  83. Surwit EA, Joelsson I, Einhorn N (1981) Adjunctive radiation therapy in the management of stage I cancer of the endometrium. Obstet Gynecol 58:590–595PubMedGoogle Scholar
  84. Trotnow S, Becker H, Paterok EM (1978) Tumour volume of endometrial cancer. In: Brush M, Taylor RW (eds) Endometrial cancer. Baillière Tindall, EastbourneGoogle Scholar
  85. Vongtama V, Kurohara SS, Badib AO, Webster JH (1970) The value of adjuvant irradiation in the treatment of endometrial carcinoma stage I group 1. Cancer 25:45–49PubMedCrossRefGoogle Scholar
  86. Wade ME, Kohorn EI, Morris JM (1967) Adenocarcinoma of the endometrium: evaluation of preoperative irradiation and factors influencing prognosis. Am J Obstet Gynecol 99:869–876PubMedGoogle Scholar
  87. Wallin TE, Malkasian GD, Gaffey TA et al. (1984) Stage II cancer of the endometrium: a pathologic and clinical study. Gynecol Oncol 18:1–17PubMedCrossRefGoogle Scholar
  88. Weed JC, Greary WL, Holland JB (1966) Adenomyosis of the uterus. Clin Obstet Gynecol 9:412–421PubMedCrossRefGoogle Scholar
  89. Weiser EB, Hoskins WJ, Bibro MC et al. (1985) Papillary adenocarcinoma of the endometrium. Gynecol Oncol 20:249CrossRefGoogle Scholar
  90. Welander CA, Griem ML, Newton M, Marks JE (1972) Staging and treatment of endometrial carcinoma. J Reprod Med 8:41–46PubMedGoogle Scholar
  91. Wu BZ, Tang MY, Lang JH (1982) Endometrial carcinoma. In: Lin QZ (ed) Gynecologic oncology. People’s Medical Publishing House, Beijing, p 85–104Google Scholar
  92. Yazigi R, Piver MS, Blumenson L (1983) Malignant peritoneal cytology as prognostic indicator in stage I endometrial cancer. Obstet Gynecol 62:359–362PubMedCrossRefGoogle Scholar
  93. Yoonessi M, Anderson DG, Morley GW (1979) Endometrial carcinoma: causes of death and sites of treatment failure. Cancer 43:1944–1950PubMedCrossRefGoogle Scholar
  94. Young PCM, Ehrlich CE (1979) Progesterone receptors in human endometrial cancer. In: Thompson EB, Lippman ME (eds) Steroid receptors and the management of cancer, Vol I. CRC Press, Boca Raton, p 135–160Google Scholar

Copyright information

© The People’s Medical Publishing House Beijing and Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  1. 1.Gynecologic Oncology DepartmentCancer Institute (Hospital) Chinese Academy of Medical SciencesBeijingP.R.China

Personalised recommendations